1st Circuit Affirms Defense Verdict In Pondimin Lung Injury Case

(March 24, 2016, 11:51 AM EDT) -- BOSTON — A First Circuit U.S. Court of Appeals panel on March 23 affirmed a defense verdict in a Pondimin diet drug primary pulmonary hypertension (PPH) case, finding in part that the plaintiff failed to show a reasonable alternative design for the drug (Michael J. Tersigni v. Wyeth, et al., No. 14-1927, 1st Cir.; 2016 U.S. App. LEXIS 5393).

(Opinion available. Document #28-160407-012Z.)

From early 1997 to July 1997, Michael J. Tersigni took Pondimin, a prescription weight loss drug made by Wyeth (now Pfizer Inc.). Tersigni’s...
To view the full article, register now.